These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18226447)

  • 1. Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia.
    Golovko MY; Murphy EJ
    Neurosci Lett; 2008 Feb; 432(3):243-7. PubMed ID: 18226447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids.
    Golovko MY; Rosenberger TA; Feddersen S; Faergeman NJ; Murphy EJ
    J Neurochem; 2007 Apr; 101(1):201-11. PubMed ID: 17250657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism.
    Golovko MY; Rosenberger TA; Faergeman NJ; Feddersen S; Cole NB; Pribill I; Berger J; Nussbaum RL; Murphy EJ
    Biochemistry; 2006 Jun; 45(22):6956-66. PubMed ID: 16734431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response.
    Golovko MY; Barceló-Coblijn G; Castagnet PI; Austin S; Combs CK; Murphy EJ
    Mol Cell Biochem; 2009 Jun; 326(1-2):55-66. PubMed ID: 19116775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction.
    Golovko MY; Murphy EJ
    J Lipid Res; 2008 Apr; 49(4):893-902. PubMed ID: 18187404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice.
    Barceló-Coblijn G; Golovko MY; Weinhofer I; Berger J; Murphy EJ
    J Neurochem; 2007 Apr; 101(1):132-41. PubMed ID: 17250686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
    Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
    Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of the Multimerin-1 Gene in α-Synuclein Knokout Mice.
    Chaprov KD; Goloborshcheva VV; Tarasova TV; Teterina EV; Korokin MV; Soldatov VO; Pokrovskiy MV; Kucheryanu VG; Morozov SG; Ovchinnikov RK
    Dokl Biol Sci; 2020 Sep; 494(1):260-263. PubMed ID: 33083886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte arachidonate and palmitate uptake and metabolism is differentially modulated by dibutyryl-cAMP treatment.
    Seeger DR; Murphy CC; Murphy EJ
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jul; 110():16-26. PubMed ID: 27255639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
    Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
    Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.
    Woerman AL; Oehler A; Kazmi SA; Lee J; Halliday GM; Middleton LT; Gentleman SM; Mordes DA; Spina S; Grinberg LT; Olson SH; Prusiner SB
    Acta Neuropathol; 2019 Mar; 137(3):437-454. PubMed ID: 30690664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of acyl-CoA esters and acyl-CoA synthetase activity in mouse brain areas by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Kasuya F; Masuyama T; Yamashita T; Nakamoto K; Tokuyama S; Kawakami H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():45-50. PubMed ID: 23644500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of α-synuclein expression in cultured cortical neurons.
    Clough RL; Dermentzaki G; Haritou M; Petsakou A; Stefanis L
    J Neurochem; 2011 Apr; 117(2):275-85. PubMed ID: 21272005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous oxygen is required for prostanoid induction under brain ischemia as evidence for a novel regulatory mechanism.
    Seeger DR; Schofield B; Besch D; Golovko SA; Kotha P; Parmer M; Solaymani-Mohammadi S; Golovko MY
    J Lipid Res; 2023 Nov; 64(11):100452. PubMed ID: 37783389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.
    Scherzer CR; Grass JA; Liao Z; Pepivani I; Zheng B; Eklund AC; Ney PA; Ng J; McGoldrick M; Mollenhauer B; Bresnick EH; Schlossmacher MG
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10907-12. PubMed ID: 18669654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma.
    Komaba J; Matsuda D; Shibakawa K; Nakade S; Hashimoto Y; Miyata Y; Ogawa M
    Biomed Chromatogr; 2009 Mar; 23(3):315-23. PubMed ID: 18800333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
    Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
    Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive "low footprint" genetic knockout of alpha-synuclein.
    Goloborshcheva VV; Chaprov KD; Teterina EV; Ovchinnikov R; Buchman VL
    Mol Brain; 2020 May; 13(1):75. PubMed ID: 32393371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.